title: The ABSORB III Trial: Potential New Concepts for Intracranial Atherosclerosis in the Post-SAMMPRIS Era.
authors.affiliation: *Mayo Clinic ‡University of Arizona College of Medicine, Phoenix, Arizona.
authors.forename: Rami James N
authors.initials: RJ
authors.lastname: Aoun
authors.forename: Mithun G
authors.initials: MG
authors.lastname: Sattur
authors.forename: Roshan S
authors.initials: RS
authors.lastname: Panchanathan
authors.forename: Bernard R
authors.initials: BR
authors.lastname: Bendok
mesh_terms: D020341:Absorbable Implants; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D000068338:Everolimus / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus